Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 17/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | APAF1 | O14727 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20864360 | 0.85 | BRD4 (0.56) | BRD4ALDH1A1MAPTSMN1; SMN2PKM | |
| SCHEMBL14527677 | 0.82 | BRD4 (0.55) | BRD4ALDH1A1MAPTSMN1; SMN2PKM | |
| SCHEMBL25520367 | 0.81 | ALDH1A1 (0.47) | BRD4KDM4EALDH1A1APAF1GAA | |
| SCHEMBL20864358 | 0.81 | ALDH1A1 (0.56) | KDM4EALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL17992501 | 0.77 | ALDH1A1 (0.71) | BRD4KDM4EALDH1A1APAF1GAA | |
| SCHEMBL30097952 | 0.76 | HTR7 (0.56) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL28950254 | 0.76 | HTR7 (0.56) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL918303 | 0.74 | TDP1 (0.51) | MAPTSMN1; SMN2L3MBTL1 | |
| SCHEMBL14023220 | 0.74 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL20864359 | 0.73 | BRD4 (0.54) | BRD4ALDH1A1MAPTSMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159762-A1 | NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION | REVVITY HEALTH SCIENCES, INC. | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159762-A1 | NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION | SMARCD1, SMARCE1, SMARCB1 | BRD4 323/4885KDM4E 2640/4885ALDH1A1 3287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.